Cresco Labs (CRLBF) Return on Capital Employed (2021 - 2026)
Cresco Labs (CRLBF) posted Return on Capital Employed of 2.76% for Q1 2026, down 12.46% on a QoQ basis from 2.46% in Q4 2025, and down 1012.0% year-over-year from 0.3% in Q1 2025.
Cresco Labs (CRLBF) Return on Capital Employed (2021 - 2026) Analysis & Trends
Cresco Labs' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 2.76% for Q1 2026.
- Quarterly Return on Capital Employed fell 1012.0% year-over-year to 2.76% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.76% (down 1012.0% YoY) and the FY2025 annual result came in at 2.38%, down 1088.0% from the prior year.
- Return on Capital Employed was 2.76% for Q1 2026 at Cresco Labs, down from 2.46% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 9.49% in Q3 2024 and bottomed at 21.64% in Q3 2023.
- A 5-year average of 2.62% and a median of 2.76% in 2026 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed tumbled 2676 bps — and 2024, when it jumped 3112 bps.
- Cresco Labs' Return on Capital Employed stood at 5.96% in 2022, then dropped by 25 bps to 7.45% in 2023, then surged by 213 bps to 8.42% in 2024, then slumped by 129 bps to 2.46% in 2025, then decreased by 12 bps to 2.76% in 2026.
- Business Quant data shows CRLBF's Return on Capital Employed at 2.76% in Q1 2026, 2.46% in Q4 2025, and 5.5% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.43% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.24% |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | -2.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.76% |
| Dec 31, 2025 | -2.46% |
| Sep 30, 2025 | 5.50% |
| Jun 30, 2025 | 6.02% |
| Mar 31, 2025 | 7.36% |
| Dec 31, 2024 | 8.42% |
| Sep 30, 2024 | 9.49% |
| Jun 30, 2024 | -1.56% |
| Mar 31, 2024 | -5.41% |
| Dec 31, 2023 | -7.45% |
| Sep 30, 2023 | -21.64% |
| Jun 30, 2023 | -10.39% |
| Mar 31, 2023 | -7.80% |
| Dec 31, 2022 | -5.96% |
| Sep 30, 2022 | 5.13% |
| Jun 30, 2022 | -9.98% |
| Mar 31, 2022 | -10.96% |
| Dec 31, 2021 | -11.76% |
| Mar 31, 2021 | 1.97% |